Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Medicale (MCLE) Debt to Equity (2020 - 2023)

Medicale's Debt to Equity history spans 4 years, with the latest figure at -$0.5 for Q3 2023.

  • For Q3 2023, Debt to Equity rose 22.5% year-over-year to -$0.5; the TTM value through Sep 2023 reached -$0.5, up 22.5%, while the annual FY2023 figure was -$0.5, 22.5% up from the prior year.
  • Debt to Equity reached -$0.5 in Q3 2023 per MCLE's latest filing, up from -$0.65 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.37 in Q1 2021 to a low of -$2.78 in Q3 2021.
  • Average Debt to Equity over 4 years is -$0.59, with a median of -$0.58 recorded in 2022.
  • The largest YoY upside for Debt to Equity was 76.69% in 2022 against a maximum downside of 150.39% in 2022.
  • A 4-year view of Debt to Equity shows it stood at -$0.31 in 2020, then tumbled by 38.83% to -$0.43 in 2021, then tumbled by 50.95% to -$0.65 in 2022, then increased by 22.5% to -$0.5 in 2023.
  • Per Business Quant, the three most recent readings for MCLE's Debt to Equity are -$0.5 (Q3 2023), -$0.65 (Q3 2022), and -$0.7 (Q2 2022).